ResearcherUniversity of Rome Tor VergataActive in the last 2 years
Ivano Amelio
Matched on ORCID iD 0000-0002-9126-5391; OpenAlex author ID A5029652806. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 23
2022: 2 papers · 2023: none · 2024: 2 papers · 2025: 1 paper
Papers 5
- Lipidome atlas of p53 mutant variants in pancreatic cancer. Co-author DOI 10.1186/s13062-025-00635-w↗
- Axon guidance cue SEMA3A promotes the aggressive phenotype of basal-like PDAC. Co-author DOI 10.1136/gutjnl-2023-329807↗
- Selective metabolic regulations by p53 mutant variants in pancreatic cancer. Last author DOI 10.1186/s13046-024-03232-3↗
- p53 mutations define the chromatin landscape to confer drug tolerance in pancreatic cancer. Last author DOI 10.1002/1878-0261.13161↗
- p53-driven lipidome influences non-cell-autonomous lysophospholipids in pancreatic cancer. Last author DOI 10.1186/s13062-022-00319-9↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Alessio Butera · 3 shared papers, 2022–2025 · strength 0.60
- Paper Lipidome atlas of p53 mutant variants in pancreatic cancer. DOI 10.1186/s13062-025-00635-w↗
- Paper Selective metabolic regulations by p53 mutant variants in pancreatic cancer. DOI 10.1186/s13046-024-03232-3↗
- Paper p53-driven lipidome influences non-cell-autonomous lysophospholipids in pancreatic cancer. DOI 10.1186/s13062-022-00319-9↗
- Angelo D’Alessandro · 3 shared papers, 2022–2025 · strength 0.60
- Paper Lipidome atlas of p53 mutant variants in pancreatic cancer. DOI 10.1186/s13062-025-00635-w↗
- Paper Selective metabolic regulations by p53 mutant variants in pancreatic cancer. DOI 10.1186/s13046-024-03232-3↗
- Paper p53-driven lipidome influences non-cell-autonomous lysophospholipids in pancreatic cancer. DOI 10.1186/s13062-022-00319-9↗
- Carlotta Zampieri · 3 shared papers, 2022–2024 · strength 0.53
- Paper p53 mutations define the chromatin landscape to confer drug tolerance in pancreatic cancer. DOI 10.1002/1878-0261.13161↗
- Paper Selective metabolic regulations by p53 mutant variants in pancreatic cancer. DOI 10.1186/s13046-024-03232-3↗
- Paper p53-driven lipidome influences non-cell-autonomous lysophospholipids in pancreatic cancer. DOI 10.1186/s13062-022-00319-9↗
- Sabrina Caporali · 2 shared papers, 2024–2025 · strength 0.43
- Vincenzo Corbo · 2 shared papers, 2022–2024 · strength 0.34
- Kian Cotton · 1 shared paper, 2025 · strength 0.26
- Maria Victoria Niklison-Chirou · 1 shared paper, 2025 · strength 0.26
- Luigi Leanza · 1 shared paper, 2024 · strength 0.18
- Francesca Lupo · 1 shared paper, 2024 · strength 0.15
- Peter J. Bailey · 1 shared paper, 2024 · strength 0.15
- Vincenzo Bronte · 1 shared paper, 2024 · strength 0.15
- Francesco De Sanctis · 1 shared paper, 2024 · strength 0.15
- Pietro Delfino · 1 shared paper, 2024 · strength 0.15
- Antonia Malinova · 1 shared paper, 2024 · strength 0.15
- Sabrina L. D’Agosto · 1 shared paper, 2024 · strength 0.15
- Rita Teresa Lawlor · 1 shared paper, 2024 · strength 0.15
- Lisa Veghini · 1 shared paper, 2024 · strength 0.15
- Geny Piro · 1 shared paper, 2024 · strength 0.15
- Elena Fiorini · 1 shared paper, 2024 · strength 0.15
- Chang‐Il Hwang · 1 shared paper, 2024 · strength 0.15
- Carmine Carbone · 1 shared paper, 2024 · strength 0.15
- David Arthur Tuveson · 1 shared paper, 2024 · strength 0.15
- Aldo Scarpa Scarpa · 1 shared paper, 2024 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.